Krystal Biotech to Participate in Bank of America Merrill Lynch Global Healthcare Conference

Rhea-AI Summary

PITTSBURGH, May 3, 2022 - Krystal Biotech, Inc. (NASDAQ: KRYS), a leader in redosable gene therapy, announced that CEO Krish S. Krishnan will speak at the Bank of America Merrill Lynch Global Healthcare Conference on May 10, 2022, at 9:20 AM PDT. The event will be accessible via webcast at this link. A replay will be available on the company's website for 90 days after the event. Krystal Biotech focuses on developing gene therapies for serious conditions, particularly rare diseases.

PITTSBURGH, May 03, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer, will participate in the Bank of America Merrill Lynch Global Healthcare Conference.

Details for the event are as follows:

Bank of America Merrill Lynch Global Healthcare Conference
Date:		Tuesday, May 10, 2022
Time:		9:20am PDT
Webcast Link:		https://bofa.veracast.com/webcasts/bofa/hc2022/id6InQpA.cfm

A webcast of the presentation will be available on the Investors section of the Company’s website for 90 days following the presentation.

About Krystal Biotech

Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company leveraging its proprietary, redosable gene therapy platform and in-house manufacturing capabilities to develop life-changing treatment options for patients with serious diseases, including rare diseases in skin, lung, and other areas. For more information, please visit http://www.krystalbio.com and follow @KrystalBiotech on LinkedIn and Twitter.

CONTACT:

Investors and Media:
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com

Source: Krystal Biotech, Inc.

FAQ

When will Krystal Biotech participate in the Bank of America Merrill Lynch Global Healthcare Conference?

Krystal Biotech will participate in the Bank of America Merrill Lynch Global Healthcare Conference on May 10, 2022.

What time is Krystal Biotech's presentation at the conference?

Krystal Biotech's presentation is scheduled for 9:20 AM PDT.

Where can I watch the Krystal Biotech presentation?

The presentation can be watched via webcast at this link.

How long will the webcast of the Krystal Biotech presentation be available?

The webcast of the Krystal Biotech presentation will be available for 90 days after the event.

What is the focus of Krystal Biotech's gene therapy development?

Krystal Biotech focuses on developing gene therapies for serious diseases, including rare conditions affecting skin and lungs.